Not Yet RecruitingNot Applicable

Perioperative Rehabilitation Therapy in Patients Undergoing Liver Transplantation

750 participantsStarted 2024-10-01

Plain-language summary

Patients undergoing liver transplantation frequently experience a reduction in skeletal muscle mass, malnutrition, and decreased levels of physical activity. These complications can adversely affect early postoperative recovery and the therapeutic effect of the transplant. This clinical study aims to investigate the effects of nutritional supplementation and rehabilitation therapy on sarcopenia associated with liver transplantation in adults. The goal is to establish a comprehensive perioperative intervention strategy to reduce the incidence of postoperative sarcopenia and improve transplantation outcomes.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age between 18 and 70 years.
✓. Patients with end-stage liver disease who meet the criteria for liver transplantation (for liver cancer cases, only recipients meeting specific standards are included).
✓. Complete clinical information, including documented pre-transplant muscle status (e.g., preoperative CT scans and handgrip strength tests).
✓. High compliance with treatment, fully capable of independent action or having at least one assistant.
✓. No contraindications to the planned interventions.

Exclusion criteria

✕. Presence of musculoskeletal disorders before transplantation, such as myositis, idiopathic muscle atrophy, or history of hip surgery within the past three months.
✕. Coexisting severe cardiovascular or cerebrovascular diseases, infectious diseases, or epilepsy.
✕. Liver transplantation due to autoimmune liver disease or drug-induced liver failure.
✕. Re-transplantation, multi-organ transplantation, living donor liver transplantation, split liver transplantation, or pediatric liver transplantation.
✕. ABO-incompatible liver transplantation.
✕. Incomplete clinical information.
✕. Difficulty in follow-up.

What they're measuring

2-year overall survival

Timeframe: From enrollment to the end of follow-up at 2 years

Trial details

NCT IDNCT06591507

SponsorZhejiang University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-12-31

Contact for this trial

Zuyuan Lin

+8613606536446 3130102029@zju.edu.cn

View on ClinicalTrials.gov More Liver Transplantation trials